Quantum BioPharma Ltd. (QNTM) — Cash Flow-to-Debt Ratio
Quantum BioPharma Ltd. (QNTM) has a Cash Flow-to-Debt Ratio of -0.26x as of September 2025, meaning its operating cash flow of $-1.72 Million could theoretically repay 0% of its total liabilities ($6.65 Million) in one year. See working capital to net assets of Quantum BioPharma Ltd. to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Quantum BioPharma Ltd. Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Quantum BioPharma Ltd. across 10 annual periods. Also explore QNTM year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Quantum BioPharma Ltd. (2015–2024)
Year-by-year debt coverage analysis for Quantum BioPharma Ltd.. For market capitalisation and broader financial context, see Quantum BioPharma Ltd. (QNTM) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.03x | $-6.88 Million | $6.68 Million | ▲ +56.6% |
| 2023 | -2.37x | $-10.83 Million | $4.57 Million | ▲ +34.1% |
| 2022 | -3.60x | $-28.33 Million | $7.87 Million | ▼ -53.3% |
| 2021 | -2.35x | $-20.75 Million | $8.83 Million | ▲ +30.5% |
| 2020 | -3.38x | $-19.13 Million | $5.66 Million | ▼ -71.1% |
| 2019 | -1.98x | $-13.71 Million | $6.94 Million | ▲ +81.4% |
| 2018 | -10.60x | $-13.58 Million | $1.28 Million | ▼ -8857.1% |
| 2017 | -0.12x | $-119.18K | $1.01 Million | ▲ +73.3% |
| 2016 | -0.44x | $-27.24K | $61.43K | ▼ -42203.9% |
| 2015 | 0.00x | $-63.44 | $60.53K | — |